Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR.
Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR.
Nephrology (Carlton). 2022 Feb;27(2):171-180. doi: 10.1111/nep.14007. Epub 2021 Dec 10.
To evaluate the demographics and long-term patient outcomes of children with end-stage kidney disease in Hong Kong.
We conducted a cohort study at the Paediatric Nephrology Centre, the designated site providing kidney replacement therapy (KRT) for children in Hong Kong. The clinical characteristics and outcomes of all children who initiated chronic KRT before 19 years, between 2001 and 2020, were analysed.
One hundred forty-seven children (50% male) received KRT at a mean age of 11.4 ± 5.7 years. The incidence of ESKD was 6.28 per million age-related population (pmarp). The leading cause of ESKD was congenital anomalies (33%). Ten children (7%) had pre-emptive kidney transplants, 104 (71%) and 33 (22%) patients received automated peritoneal dialysis and haemodialysis as initial KRT. The incidence of ESKD increased over time, and were 4.38, 5.07, 6.15 and 9.17 pmarp during 2001-2005, 2006-2010, 2011-2015 and 2016-2020, respectively (p = .005). Ninty-seven patients (66%) received kidney transplants and the median time to receive a kidney graft was 3.7 years (95% CI 3.1-4.3). Only 10 patients had pre-emptive kidney transplants. The mortality rate was 9.1 deaths per 1000-patient-years (95%CI 4.6-16.2). The survival probabilities at 1-, 5-, 10- and 15-year were 100%, 94.8% (95%CI 90.7-98.9%), 89.7% (95% CI 83.4%-95.9%), 87.1% (95% CI 79.3%-94.9%), respectively. Standardised mortality ratio was 54.5. 72% of deaths were due to infections. Young infants and those without kidney transplants were associated with worse survival (p < .01). Multivariate analysis demonstrated that dialysis was the only factor associated with significantly increased risk of death (HR 12.9, 95% CI 2.7-63.2, p = .002).
We observed an increasing incidence of paediatric ESKD in Hong Kong with considerable waiting time to kidney transplant. Mortality risk is comparable to other developed countries and is highest among dialysis population. Efforts should be made to facilitate early access to paediatric kidney transplantation in Hong Kong.
评估香港终末期肾病儿童的人口统计学特征和长期患者结局。
我们在香港儿科肾脏病中心进行了一项队列研究,该中心是为香港儿童提供肾脏替代治疗(KRT)的指定地点。分析了 2001 年至 2020 年期间所有在 19 岁之前开始慢性 KRT 的儿童的临床特征和结局。
147 名儿童(50%为男性)在平均年龄为 11.4±5.7 岁时接受 KRT。ESKD 的发病率为每百万年龄相关人口 6.28(pmarp)。ESKD 的主要原因是先天性异常(33%)。10 名儿童(7%)进行了预防性肾移植,104 名(71%)和 33 名(22%)患者接受自动腹膜透析和血液透析作为初始 KRT。ESKD 的发病率随时间而增加,2001-2005 年、2006-2010 年、2011-2015 年和 2016-2020 年分别为 4.38、5.07、6.15 和 9.17 pmarp(p=0.005)。97 名儿童(66%)接受了肾移植,接受肾移植的中位时间为 3.7 年(95%CI 3.1-4.3)。只有 10 名儿童进行了预防性肾移植。死亡率为每 1000 名患者年 9.1 例死亡(95%CI 4.6-16.2)。1 年、5 年、10 年和 15 年的生存率分别为 100%、94.8%(95%CI 90.7-98.9%)、89.7%(95%CI 83.4%-95.9%)和 87.1%(95%CI 79.3%-94.9%)。标准化死亡率比为 54.5。72%的死亡是由感染引起的。婴儿和未接受肾移植的儿童与生存率较差有关(p<0.01)。多变量分析表明,透析是唯一与死亡风险显著增加相关的因素(HR 12.9,95%CI 2.7-63.2,p=0.002)。
我们观察到香港儿童终末期肾病的发病率呈上升趋势,等待肾移植的时间相当长。死亡率风险与其他发达国家相当,在透析人群中最高。应努力促进香港儿童尽早接受儿科肾移植。